SS Innovations International, Inc. Form 8-K Filing

This Form 8-K filing by SS Innovations International, Inc. (SSi) on June 15, 2026, announces the release of their updated June 2026 Company Presentation. This presentation, intended for shareholders and the investment community, details the company's vision, snapshot, investment highlights, leadership, market trends, and the benefits of their advanced, cost-efficient surgical robotics platform, the SSi Mantra 3. The filing also includes financial summaries for FY 2023-2025 and Q1 2025-2026, showcasing significant revenue growth and expanding gross margins. SSi highlights its global expansion strategy, regulatory progress (including anticipated FDA and EU CE Mark approvals), and its pioneering telesurgery capabilities. The presentation emphasizes the company's commitment to improving access to surgical robotics worldwide, particularly in underserved regions, while detailing the technological advancements and market opportunities of their SSi Mantra system and related instruments.